Publication | Open Access

A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic

VaccinationMedicineStrong Adjuvant ActivityImmunologyAntiviral Drug DevelopmentMolecular BiologyVirologyAntiviral ResponseInfluenza VaccineViral Structural ProteinImmunotherapyInfluenza Virus ReplicationTlr3 LigandInfluenza Vaccines